surmount-osa trial tirzepatide results In the two trials, researchers assessed the efficacy and safety of for the treatment of adults with obstructive sleep apnea and obesity. Full of both trials and Plain Language Metabolic Therapy for OSA: Will

Petrova, Pietras, K., Pili, R., Pollard, J.W., Post, M.J., Quax, P.H.A., Rabinovich, G.A., Raica, M., Randi, A.M., Ribatti, D., Ruegg, C., Schlingemann, R.O., Schulte-Merker, S., Smith, L.E.H., Song, J.W., Stacker, S.A., Stalin, J., Stratman, A.N., Van de Velde, M., van Hinsbergh, V.W.M., Vermeulen, P.B., Waltenberger, J., Weinstein, B.M., Xin, H., Yetkin-Arik, B., Yla-Herttuala, S., Yoder, M.C., and Griffioen, A.W., "Consensus guidelines for the use and interpretation of angiogenesis assays", Angiogenesis 21 (3): 425-532 (2018)

Gradual tapering may be recommended to minimize side effects

10.1200/jco.20.03565 89 MeirellesL

There was also no statistically significant difference in the effects of semaglutide across patients on different background medications, such as insulin, metformin, or SGLT2 inhibitors